Innoviva, Inc. (INVA)
21.03
-0.04
(-0.19%)
USD |
NASDAQ |
Aug 24, 16:00
21.03
0.00 (0.00%)
After-Hours: 20:00
Innoviva Market Cap : 1.528B for Aug. 24, 2026
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Market Cap Data
| Date | Value |
|---|---|
| August 24, 2026 | 1.528B |
| August 21, 2026 | 1.530B |
| August 20, 2026 | 1.525B |
| August 19, 2026 | 1.560B |
| August 18, 2026 | 1.544B |
| August 17, 2026 | 1.522B |
| August 14, 2026 | 1.539B |
| August 13, 2026 | 1.507B |
| August 12, 2026 | 1.512B |
| August 11, 2026 | 1.507B |
| August 10, 2026 | 1.502B |
| August 07, 2026 | 1.490B |
| August 06, 2026 | 1.533B |
| August 05, 2026 | 1.490B |
| August 04, 2026 | 1.515B |
| August 03, 2026 | 1.533B |
| July 31, 2026 | 1.548B |
| July 30, 2026 | 1.566B |
| July 29, 2026 | 1.597B |
| July 28, 2026 | 1.610B |
| July 27, 2026 | 1.572B |
| July 24, 2026 | 1.582B |
| July 23, 2026 | 1.565B |
| July 22, 2026 | 1.582B |
| July 21, 2026 | 1.593B |
| Date | Value |
|---|---|
| July 20, 2026 | 1.571B |
| July 17, 2026 | 1.602B |
| July 16, 2026 | 1.639B |
| July 15, 2026 | 1.616B |
| July 14, 2026 | 1.605B |
| July 13, 2026 | 1.639B |
| July 10, 2026 | 1.641B |
| July 09, 2026 | 1.639B |
| July 08, 2026 | 1.656B |
| July 07, 2026 | 1.642B |
| July 06, 2026 | 1.610B |
| July 02, 2026 | 1.647B |
| July 01, 2026 | 1.616B |
| June 30, 2026 | 1.676B |
| June 29, 2026 | 1.708B |
| June 26, 2026 | 1.740B |
| June 25, 2026 | 1.723B |
| June 24, 2026 | 1.745B |
| June 23, 2026 | 1.738B |
| June 22, 2026 | 1.673B |
| June 18, 2026 | 1.660B |
| June 17, 2026 | 1.671B |
| June 16, 2026 | 1.669B |
| June 15, 2026 | 1.655B |
| June 12, 2026 | 1.678B |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Zevra Therapeutics, Inc. | 691.33M |
| Collegium Pharmaceutical, Inc. | 888.83M |
| CorMedix, Inc. | 643.08M |
| ANI Pharmaceuticals, Inc. | 1.704B |
| Corcept Therapeutics, Inc. | 13.30B |
Market Cap Related Metrics
| PE Ratio | 5.123 |
| PS Ratio | 3.806 |
| PEG Ratio | 0.0045 |
| Price to Book Value | 1.239 |
| Price to Free Cash Flow | 9.117 |
| Price | 21.03 |
| Earnings Yield | 19.52% |
| PEGY Ratio | 0.0045 |
| Operating PE Ratio | 10.62 |
| Normalized PE Ratio | 9.198 |